Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.
Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Ngo LH, Deswal M, Munter SE, Martinez EO, Anglin KA, Romero MD, Tavs J, Rugart PR, Chen JY, Sans HM, Murray VW, Ellis PK, Donohue KC, Massachi JA, Weiss JO, Mehdi I, Pineda-Ramirez J, Tang AF, Wenger MA, Assenzio MT, Yuan Y, Krone MR, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Sauceda JA, Gandhi M, Scheffler AW, Hsue PY, Henrich TJ, Deeks SG, Martin JN. Peluso MJ, et al. Among authors: tai v. Open Forum Infect Dis. 2021 Dec 21;9(2):ofab640. doi: 10.1093/ofid/ofab640. eCollection 2022 Feb. Open Forum Infect Dis. 2021. PMID: 35106317 Free PMC article.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J Jr, Trinh L, Wrin T, Petroplolous CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. Peluso MJ, et al. Among authors: tai v. medRxiv [Preprint]. 2021 Mar 5:2021.03.03.21251639. doi: 10.1101/2021.03.03.21251639. medRxiv. 2021. Update in: Sci Adv. 2021 Jul 30;7(31):eabh3409. doi: 10.1126/sciadv.abh3409. PMID: 33688675 Free PMC article. Updated. Preprint.
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. Peluso MJ, et al. Among authors: tai v. medRxiv [Preprint]. 2021 Mar 1:2021.02.26.21252308. doi: 10.1101/2021.02.26.21252308. medRxiv. 2021. Update in: Cell Rep. 2021 Aug 10;36(6):109518. doi: 10.1016/j.celrep.2021.109518. PMID: 33688685 Free PMC article. Updated. Preprint.
Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study.
Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA. Santiago-Rodriguez EI, et al. Among authors: tai v. medRxiv [Preprint]. 2021 Mar 24:2021.03.10.21253330. doi: 10.1101/2021.03.10.21253330. medRxiv. 2021. Update in: Int J Behav Med. 2022 Oct;29(5):610-623. doi: 10.1007/s12529-021-10045-7. PMID: 33758881 Free PMC article. Updated. Preprint.
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19.
Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Bautista JA, Ngo LH, Deswal M, Munter SE, Martinez EO, Anglin KA, Romero MD, Tavs J, Rugart PR, Chen JY, Sans HM, Murray VW, Ellis PK, Donohue KC, Massachi JA, Weiss JO, Mehdi I, Pineda-Ramirez J, Tang AF, Wenger M, Assenzio M, Yuan Y, Krone M, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Sauceda JA, Gandhi M, Hsue PY, Henrich TJ, Deeks SG, Martin JN. Peluso MJ, et al. Among authors: tai v. medRxiv [Preprint]. 2021 Mar 12:2021.03.11.21252311. doi: 10.1101/2021.03.11.21252311. medRxiv. 2021. Update in: Open Forum Infect Dis. 2021 Dec 21;9(2):ofab640. doi: 10.1093/ofid/ofab640. PMID: 33758895 Free PMC article. Updated. Preprint.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Donatelli J, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J Jr, Trinh L, Wrin T, Petropoulos CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. Peluso MJ, et al. Among authors: tai v. Sci Adv. 2021 Jul 30;7(31):eabh3409. doi: 10.1126/sciadv.abh3409. Print 2021 Jul. Sci Adv. 2021. PMID: 34330709 Free PMC article.
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. Peluso MJ, et al. Among authors: tai v. Cell Rep. 2021 Aug 10;36(6):109518. doi: 10.1016/j.celrep.2021.109518. Epub 2021 Aug 6. Cell Rep. 2021. PMID: 34358460 Free PMC article.
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency.
Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodríguez-Barraquer I. Takahashi S, et al. Among authors: tai v. medRxiv [Preprint]. 2021 Sep 14:2021.09.09.21263139. doi: 10.1101/2021.09.09.21263139. medRxiv. 2021. Update in: Am J Epidemiol. 2023 Sep 1;192(9):1562-1575. doi: 10.1093/aje/kwad106. PMID: 34545373 Free PMC article. Updated. Preprint.
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, Forman CA, Munter SE, Hoh R, Tai V, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Greenhouse B, Hunt PW, Hsue PY, Martin JN, Daniel Kelly J, Glidden DV, Deeks SG, Henrich TJ. Peluso MJ, et al. Among authors: tai v. J Infect Dis. 2021 Dec 1;224(11):1839-1848. doi: 10.1093/infdis/jiab490. J Infect Dis. 2021. PMID: 34677601 Free PMC article.
Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.
Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA. Santiago-Rodriguez EI, et al. Among authors: tai v. Int J Behav Med. 2022 Oct;29(5):610-623. doi: 10.1007/s12529-021-10045-7. Epub 2021 Dec 16. Int J Behav Med. 2022. PMID: 34918211 Free PMC article.
133 results